Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human CD23/Fc epsilon RII Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 2 publications
Supplier: R&D Systems AF123
This item is not returnable.
View return policy
Description
CD23/Fc epsilon RII Polyclonal specifically detects CD23/Fc epsilon RII in Human samples. It is validated for Western Blot, Blockade of Receptor-ligand Interaction, Immunocytochemistry.Specifications
CD23/Fc epsilon RII | |
Polyclonal | |
Unconjugated | |
P06734 | |
FCER2 | |
Mouse myeloma cell line NS0-derived recombinant human CD23/Fc epsilon RII Met150-Ser321 Accession # P06734 | |
100 μg | |
Primary | |
Detects human CD23/Fc epsilon RII in direct ELISAs and Western blots. | |
Human | |
IgG |
Western Blot, Blockade of Receptor-ligand Interaction, Immunocytochemistry | |
LYOPH | |
Western Blot 0.1 ug/mL, Blockade of Receptor-ligand Interaction, Immunocytochemistry 5-15 ug/mL | |
BLAST-2, CD23, CD23A, CD23CD23 antigen, CLEC4J, CLEC4JC-type lectin domain family 4 member J, C-type lectin domain family 4, member J, Fc epsilon RII, Fc fragment of IgE, low affinity II, receptor for (CD23), FCE2Fc fragment of IgE, low affinity II, receptor for (CD23A), fc-epsilon-RII, FCER2, Fcer2a, FceRII, IGEBF, Immunoglobulin E-binding factor, low affinity immunoglobulin epsilon Fc receptor, Ly-42, Lymphocyte IgE receptor | |
Goat | |
Affinity Purified | |
RUO | |
2208 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction